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Arthritis, with osteoarthritis (OA) accounting for most of
this burden, is a leading cause of disability in the western
world. Symptomatic full-thickness defects of the knee joint
surface require surgical treatment for symptom relief and
to prevent secondary OA. Current gold standard of cell
therapy for joint surface repair consists of implantation of
autologous, culture-expanded articular chondrocytes
underneath a periosteal flap or a synthetic membrane.
Twenty years’ follow-up has proved autologous chondro-
cyte implantation (ACI) to be an effective and durable
solution for the treatment of large full-thickness cartilage
lesions of the knee joint. Articular chondrocytes, however,
are difficult to expand because of their limited proliferative
capacity and rapid de-differentiation in vitro. The use of
mesenchymal stem cells (MSCs) as chondrocyte substi-
tutes in an ACI-equivalent procedure is intensely pursued
because MSCs are easy to isolate from bone marrow or
other connective tissues such as adipose tissue and to
expand in culture, and they have ability to form cartilage
and bone. Clinical studies are ongoing to demonstrate
non-inferiority of MSCs in structural and clinical out-
comes when compared with chondrocytes. In addition to
the use of ex vivo manipulated MSCs, an attractive
approach to the repair of the joint surface is the activation
of intrinsic repair mechanisms by targeting the stem cells
naturally present in the joint. In this respect, several joint-
associated tissues such as synovium, fat pad, periosteum,
bone marrow, and even the articular cartilage itself, are
known to contain cells that, after isolation and culture
expansion, display properties of MSCs. Recently, by com-
bining a double nucleoside labelling scheme with a clini-
cally relevant mouse model of joint surface injury, we
identified endogenous resident MSCs in the knee joint
synovium in vivo. We are currently studying the functional
roles of endogenous MSCs in joint health and diseases.
Understanding the way stem cells function at their niche
sites will help develop novel treatment approaches aiming
at activating repair mechanisms to achieve tissue healing
and restore joint homeostasis.
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